Half-year report · HY
190A.TEDINET S100XYSP
Period2025-09-01 → 2026-02-28
Filed2026-04-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 42
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | −¥663m | 2025-09-01 → 2026-02-28 | Standalone | Operating income |
| Operating income | −¥996m | 2024-09-01 → 2025-02-28 | Standalone | Operating income |
| Ordinary income | −¥633m | 2025-09-01 → 2026-02-28 | Standalone | Ordinary income |
| Ordinary income | −¥1.8bn | 2024-09-01 → 2025-08-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥975m | 2024-09-01 → 2025-02-28 | Standalone | Ordinary income |
| Profit before tax | −¥633m | 2025-09-01 → 2026-02-28 | Standalone | Income before income taxes |
| Profit before tax | −¥975m | 2024-09-01 → 2025-02-28 | Standalone | Income before income taxes |
| Net income | −¥634m | 2025-09-01 → 2026-02-28 | Standalone | Profit loss |
| Net income | −¥1.8bn | 2024-09-01 → 2025-08-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥976m | 2024-09-01 → 2025-02-28 | Standalone | Profit loss |
| Total assets | ¥2.5bn | at 2026-02-28 | Standalone | Assets |
| Total assets | ¥2.7bn | at 2025-08-31 | Standalone | Assets |
| Total assets | ¥3.5bn | at 2025-02-28 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥197m | at 2026-02-28 | Standalone | Liabilities |
| Total liabilities | ¥244m | at 2025-08-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.3bn | at 2026-02-28 | Standalone | Net assets |
| Net assets / equity | ¥2.4bn | at 2025-08-31 | Standalone | Net assets |
| Net assets / equity | ¥3.2bn | at 2025-02-28 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2026-02-28 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.5bn | at 2025-08-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥2.4bn | at 2026-02-28 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.5bn | at 2025-08-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥3.3bn | at 2025-02-28 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.3bn | at 2024-08-31v | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥611m | 2025-09-01 → 2026-02-28 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.8bn | 2024-09-01 → 2025-08-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.1bn | 2024-09-01 → 2025-02-28 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | ¥53,000 | 2025-09-01 → 2026-02-28 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥5m | 2024-09-01 → 2025-08-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥667,000 | 2024-09-01 → 2025-02-28 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥510m | 2025-09-01 → 2026-02-28 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥62m | 2024-09-01 → 2025-08-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥62m | 2024-09-01 → 2025-02-28 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-8.95 | 2025-09-01 → 2026-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-26.03 | 2024-09-01 → 2025-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-14.31 | 2024-09-01 → 2025-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 91.8% | at 2026-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.8% | at 2025-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.0% | at 2025-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 73,730,900 | at 2026-02-28 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 68,988,800 | at 2025-08-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 68,988,800 | at 2025-02-28 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 334
| Item | Context | Value | Unit |
|---|---|---|---|
| Address major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)東京都港区南青山二丁目６番２１号 | |
| Name major shareholders | InterimInstant_No9MajorShareholdersMember | Text · Plus | |
| Address major shareholders | InterimInstant_No9MajorShareholdersMember | Text · Plus | |
| Name major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)株式会社メディパルホールディングス | |
| Address major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)東京都中央区京橋三丁目１番１号 | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithFullVotingRightsOtherMember | Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式であり、単元株式数は100株であります。 | |
| Description issued shares voting rights | InterimInstant_SharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | InterimDuration | Text · Plus | |
| Type1 semi annual financial statements financial information | InterimDuration | Text · Plus | |
| Note on independent audit financial information | InterimDuration | Text · Plus | |
| Description of fact that consolidated financial statements have not been prepared financial information | InterimDuration | Original text (Japanese)当社は子会社がありませんので、中間連結財務諸表は作成しておりません。 | |
| Type1 semi annual balance sheet (text) | InterimDuration | Text · Plus | |
| Type1 semi annual statement of income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual statement of cash flows (text) | InterimDuration | Text · Plus | |
| Notes regarding research and development expenses (text) | InterimDuration_NonConsolidatedMember | Text · Plus | |
| Major components of selling general and administrative expenses (text) | InterimDuration_NonConsolidatedMember | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | InterimDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1InterimDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | InterimDuration_NonConsolidatedMember | Text · Plus | |
| Notes segment information etc type1 semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | Prior1InterimDuration_NonConsolidatedMember | Original text (Japanese)当社の事業セグメントは、医薬品事業のみの単一セグメントであるため、記載を省略しております。 | |
| Description of fact that companys business comprises single segment | InterimDuration_NonConsolidatedMember | Original text (Japanese)当社の事業セグメントは、医薬品事業のみの単一セグメントであるため、記載を省略しております。 | |
| Notes revenue recognition semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Notes significant events after reporting period semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Other information financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |